ID   CAC1S_RAT               Reviewed;        1850 AA.
AC   Q02485; B3XZL8; P70484; Q01553; Q62817;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2017, sequence version 2.
DT   24-JUL-2024, entry version 164.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1S;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle;
DE   AltName: Full=ROB1;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.1;
GN   Name=Cacna1s; Synonyms=Cach1, Cacn1, Cacnl1a3, Cchl1a3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000312|EMBL:BAG54980.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Wistar {ECO:0000312|EMBL:BAG54980.1};
RC   TISSUE=Skeletal muscle {ECO:0000312|EMBL:BAG54980.1};
RX   PubMed=20101487; DOI=10.1007/s12576-010-0085-z;
RA   Tanaka N., Ishii H., Yin C., Koyama M., Sakuma Y., Kato M.;
RT   "Voltage-gated Ca2+ channel mRNAs and T-type Ca2+ currents in rat
RT   gonadotropin-releasing hormone neurons.";
RL   J. Physiol. Sci. 60:195-204(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 714-1850 (ISOFORM 1).
RX   PubMed=1335956; DOI=10.1016/s0888-7543(05)80134-x;
RA   Chin H., Krall M., Kim H.-L., Kozak C.A., Mock B.A.;
RT   "The gene for the alpha-1 subunit of the skeletal muscle dihydropyridine-
RT   sensitive calcium channel (Cchl1a3) maps to mouse chromosome 1.";
RL   Genomics 14:1089-1091(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1310-1404.
RC   TISSUE=Kidney;
RX   PubMed=1279681; DOI=10.1073/pnas.89.21.10494;
RA   Yu A.S.L., Hebert S.C., Brenner B.M., Lytton J.;
RT   "Molecular characterization and nephron distribution of a family of
RT   transcripts encoding the pore-forming subunit of Ca2+ channels in the
RT   kidney.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:10494-10498(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1072-1371 (ISOFORM ROB1).
RC   TISSUE=Osteosarcoma;
RX   PubMed=7479909; DOI=10.1073/pnas.92.24.10914;
RA   Barry E.L.R., Gesek F.A., Froehner S.C., Friedman P.A.;
RT   "Multiple calcium channel transcripts in rat osteosarcoma cells: selective
RT   activation of alpha 1D isoform by parathyroid hormone.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10914-10918(1995).
RN   [5]
RP   PHOSPHORYLATION BY PKA.
RX   PubMed=2174428; DOI=10.1016/s0021-9258(17)45292-6;
RA   Lai Y., Seagar M.J., Takahashi M., Catterall W.A.;
RT   "Cyclic AMP-dependent phosphorylation of two size forms of alpha 1 subunits
RT   of L-type calcium channels in rat skeletal muscle cells.";
RL   J. Biol. Chem. 265:20839-20848(1990).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-393; SER-397; SER-1575;
RP   THR-1579 AND SER-1617, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Pore-forming, alpha-1S subunit of the voltage-gated calcium
CC       channel that gives rise to L-type calcium currents in skeletal muscle.
CC       Calcium channels containing the alpha-1S subunit play an important role
CC       in excitation-contraction coupling in skeletal muscle via their
CC       interaction with RYR1, which triggers Ca(2+) release from the
CC       sarcplasmic reticulum and ultimately results in muscle contraction.
CC       Long-lasting (L-type) calcium channels belong to the 'high-voltage
CC       activated' (HVA) group. {ECO:0000250|UniProtKB:P07293,
CC       ECO:0000250|UniProtKB:Q13698}.
CC   -!- ACTIVITY REGULATION: Channel activity is blocked by dihydropyridines
CC       (DHP), phenylalkylamines, and by benzothiazepines.
CC       {ECO:0000250|UniProtKB:P07293, ECO:0000305}.
CC   -!- SUBUNIT: Component of a calcium channel complex consisting of a pore-
CC       forming alpha subunit (CACNA1S) and the ancillary subunits CACNB1 or
CC       CACNB2, CACNG1 and CACNA2D1. The channel complex contains alpha, beta,
CC       gamma and delta subunits in a 1:1:1:1 ratio, i.e. it contains either
CC       CACNB1 or CACNB2 (By similarity). CACNA1S channel activity is modulated
CC       by the auxiliary subunits (CACNB1 or CACNB2, CACNG1 and CACNA2D1).
CC       Interacts with DYSF and JSRP1 (By similarity). Interacts with RYR1.
CC       Interacts with STAC, STAC2 and STAC3 (via their SH3 domains) (By
CC       similarity). Interacts with CALM (By similarity).
CC       {ECO:0000250|UniProtKB:P07293, ECO:0000250|UniProtKB:Q02789,
CC       ECO:0000250|UniProtKB:Q13698}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma, T-tubule
CC       {ECO:0000250|UniProtKB:P07293}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P07293}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q02485-1; Sequence=Displayed;
CC       Name=ROB1;
CC         IsoId=Q02485-2; Sequence=VSP_000939;
CC   -!- TISSUE SPECIFICITY: Skeletal muscle specific.
CC   -!- DOMAIN: Each of the four internal repeats contains five hydrophobic
CC       transmembrane segments (S1, S2, S3, S5, S6) and one positively charged
CC       transmembrane segment (S4). S4 segments probably represent the voltage-
CC       sensor and are characterized by a series of positively charged amino
CC       acids at every third position. {ECO:0000250|UniProtKB:P07293}.
CC   -!- DOMAIN: The loop between repeats II and III interacts with the
CC       ryanodine receptor, and is therefore important for calcium release from
CC       the endoplasmic reticulum necessary for muscle contraction.
CC       {ECO:0000250|UniProtKB:P07293}.
CC   -!- PTM: The alpha-1S subunit is found in two isoforms in the skeletal
CC       muscle: a minor form of 212 kDa containing the complete amino acid
CC       sequence, and a major form of 190 kDa derived from the full-length form
CC       by post-translational proteolysis close to Phe-1690.
CC       {ECO:0000250|UniProtKB:P07293}.
CC   -!- PTM: Phosphorylated. Phosphorylation by PKA activates the calcium
CC       channel. Both the minor and major forms are phosphorylated in vitro by
CC       PKA. Phosphorylation at Ser-1575 is involved in beta-adrenergic-
CC       mediated regulation of the channel. {ECO:0000250|UniProtKB:P07293}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1S subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB374360; BAG54980.1; -; mRNA.
DR   EMBL; L04684; AAA40844.1; -; mRNA.
DR   EMBL; M99220; AAA40894.1; -; mRNA.
DR   EMBL; U31816; AAA89158.1; -; mRNA.
DR   PIR; A46422; A46422.
DR   RefSeq; NP_446325.1; NM_053873.1. [Q02485-1]
DR   AlphaFoldDB; Q02485; -.
DR   SMR; Q02485; -.
DR   CORUM; Q02485; -.
DR   STRING; 10116.ENSRNOP00000067264; -.
DR   BindingDB; Q02485; -.
DR   ChEMBL; CHEMBL4108; -.
DR   DrugCentral; Q02485; -.
DR   GuidetoPHARMACOLOGY; 528; -.
DR   GlyCosmos; Q02485; 1 site, No reported glycans.
DR   GlyGen; Q02485; 3 sites.
DR   iPTMnet; Q02485; -.
DR   PhosphoSitePlus; Q02485; -.
DR   PaxDb; 10116-ENSRNOP00000067264; -.
DR   GeneID; 682930; -.
DR   KEGG; rno:682930; -.
DR   AGR; RGD:70983; -.
DR   CTD; 779; -.
DR   RGD; 70983; Cacna1s.
DR   eggNOG; KOG2301; Eukaryota.
DR   InParanoid; Q02485; -.
DR   OrthoDB; 1110761at2759; -.
DR   PRO; PR:Q02485; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0044327; C:dendritic spine head; IDA:RGD.
DR   GO; GO:0031674; C:I band; ISO:RGD.
DR   GO; GO:1990454; C:L-type voltage-gated calcium channel complex; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; ISO:RGD.
DR   GO; GO:0030315; C:T-tubule; ISS:UniProtKB.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0140677; F:molecular function activator activity; ISO:RGD.
DR   GO; GO:0036094; F:small molecule binding; ISO:RGD.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; ISO:RGD.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IBA:GO_Central.
DR   GO; GO:0006816; P:calcium ion transport; IDA:RGD.
DR   GO; GO:0071313; P:cellular response to caffeine; ISS:UniProtKB.
DR   GO; GO:0007029; P:endoplasmic reticulum organization; ISO:RGD.
DR   GO; GO:0002074; P:extraocular skeletal muscle development; ISO:RGD.
DR   GO; GO:0055001; P:muscle cell development; ISO:RGD.
DR   GO; GO:0006936; P:muscle contraction; ISS:UniProtKB.
DR   GO; GO:0007520; P:myoblast fusion; ISO:RGD.
DR   GO; GO:0007528; P:neuromuscular junction development; ISO:RGD.
DR   GO; GO:0001503; P:ossification; NAS:RGD.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB.
DR   GO; GO:0061771; P:response to caloric restriction; IEP:RGD.
DR   GO; GO:0043501; P:skeletal muscle adaptation; ISO:RGD.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISO:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; ISO:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0006941; P:striated muscle contraction; ISO:RGD.
DR   Gene3D; 1.10.287.70; -; 4.
DR   Gene3D; 6.10.250.2180; -; 1.
DR   Gene3D; 6.10.250.2500; -; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 4.
DR   InterPro; IPR031688; CAC1F_C.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR050599; VDCC_alpha-1_subunit.
DR   InterPro; IPR005450; VDCC_L_a1ssu.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR45628; VOLTAGE-DEPENDENT CALCIUM CHANNEL TYPE A SUBUNIT ALPHA-1; 1.
DR   PANTHER; PTHR45628:SF9; VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL SUBUNIT ALPHA-1S; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16885; CAC1F_C; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   PRINTS; PR01634; LVDCCALPHA1S.
DR   SMART; SM01062; Ca_chan_IQ; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel.
FT   CHAIN           1..1850
FT                   /note="Voltage-dependent L-type calcium channel subunit
FT                   alpha-1S"
FT                   /id="PRO_0000053946"
FT   TOPO_DOM        1..51
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        52..70
FT                   /note="Helical; Name=S1 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        71..85
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        86..106
FT                   /note="Helical; Name=S2 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        107..115
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        116..136
FT                   /note="Helical; Name=S3 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        137..160
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        161..179
FT                   /note="Helical; Name=S4 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        180..196
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        197..218
FT                   /note="Helical; Name=S5 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        219..279
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        280..301
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        302..309
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        310..330
FT                   /note="Helical; Name=S6 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        331..432
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        433..451
FT                   /note="Helical; Name=S1 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        452..462
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        463..483
FT                   /note="Helical; Name=S2 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        484..494
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        495..514
FT                   /note="Helical; Name=S3 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        515..523
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        524..542
FT                   /note="Helical; Name=S4 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        543..561
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        562..581
FT                   /note="Helical; Name=S5 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        582..601
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        602..623
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        624..633
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        634..653
FT                   /note="Helical; Name=S6 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        654..799
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        800..818
FT                   /note="Helical; Name=S1 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        819..830
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        831..850
FT                   /note="Helical; Name=S2 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        851..866
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        867..885
FT                   /note="Helical; Name=S3 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        886..892
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        893..911
FT                   /note="Helical; Name=S4 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        912..930
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        931..950
FT                   /note="Helical; Name=S5 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        951..1000
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        1001..1021
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1022..1038
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1039..1060
FT                   /note="Helical; Name=S6 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1061..1118
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1119..1140
FT                   /note="Helical; Name=S1 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1141..1148
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1149..1170
FT                   /note="Helical; Name=S2 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1171..1180
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1181..1200
FT                   /note="Helical; Name=S3 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1201..1231
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1232..1250
FT                   /note="Helical; Name=S4 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1251..1268
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1269..1289
FT                   /note="Helical; Name=S5 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1290..1311
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        1312..1330
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1331..1356
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1357..1381
FT                   /note="Helical; Name=S6 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1382..1850
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REPEAT          38..337
FT                   /note="I"
FT                   /evidence="ECO:0000305"
FT   REPEAT          418..664
FT                   /note="II"
FT                   /evidence="ECO:0000305"
FT   REPEAT          786..1068
FT                   /note="III"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1105..1384
FT                   /note="IV"
FT                   /evidence="ECO:0000305"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          357..374
FT                   /note="Binding to the beta subunit"
FT                   /evidence="ECO:0000250|UniProtKB:Q02789"
FT   REGION          673..717
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          731..758
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          988..1077
FT                   /note="Dihydropyridine binding"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   REGION          1337..1403
FT                   /note="Dihydropyridine binding"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   REGION          1349..1391
FT                   /note="Phenylalkylamine binding"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   REGION          1522..1542
FT                   /note="Interaction with calmodulin"
FT                   /evidence="ECO:0000250|UniProtKB:Q13698"
FT   REGION          1697..1779
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           290..293
FT                   /note="Selectivity filter of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   MOTIF           612..615
FT                   /note="Selectivity filter of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   MOTIF           1012..1015
FT                   /note="Selectivity filter of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   MOTIF           1321..1324
FT                   /note="Selectivity filter of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   COMPBIAS        1..20
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        673..710
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1746..1778
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         292
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   BINDING         614
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   BINDING         1014
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   MOD_RES         393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         397
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         687
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   MOD_RES         1575
FT                   /note="Phosphoserine; by PKA and CAMK2"
FT                   /evidence="ECO:0000250|UniProtKB:P07293,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         1579
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1617
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P07293,
FT                   ECO:0007744|PubMed:22673903"
FT   CARBOHYD        1141
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        226..254
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   DISULFID        245..261
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   DISULFID        957..968
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   DISULFID        1338..1352
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   VAR_SEQ         1204..1222
FT                   /note="Missing (in isoform ROB1)"
FT                   /evidence="ECO:0000303|PubMed:7479909"
FT                   /id="VSP_000939"
FT   CONFLICT        714
FT                   /note="I -> V (in Ref. 2; AAA40844)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1261
FT                   /note="I -> T (in Ref. 4; AAA89158)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1323
FT                   /note="E -> A (in Ref. 4; AAA89158)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1845..1850
FT                   /note="AMPREP -> PCPGSLEPKVLPWAA (in Ref. 2; AAA40844)"
SQ   SEQUENCE   1850 AA;  210396 MW;  309E38319F53FF23 CRC64;
     MEPSSPQDEG LRKKQPKKPV PEILPRPPRA LFCLTLQNPL RKACISVVEW KPFETIILLT
     IFANCVALAV YLPMPEDDNN TLNLGLEKLE YFFLIVFSIE AAMKIIAYGF LFHQDAYLRS
     GWNVLDFIIV FLGVFTAILE QVNIIQTNTA PMSSKGAGLD VKALRAFRVL RPLRLVSGVP
     SLQVVLNSIF KAMLPLFHIA LLVLFMVIIY AIIGLELFKG KMHKTCYFIG TDIVATVENE
     KPSPCARTGS GRPCTINGSE CRGGWPGPNH GITHFDNFGF SMLTVYQCIS MEGWTDVLYW
     VNDAIGNEWP WIYFVTLILL GSFFILNLVL GVLSGEFTKE REKAKSRGTF QKLREKQQLE
     EDLRGYMSWI TQGEVMDVDD LREGKLSLDE GGSDTESLYE IEGLNKIIQF IRHWRQWNRV
     FRWKCHDLVK SKVFYWLVIL IVALNTLSIA SEHHNQPLWL THLQDVANRV LLALFTIEML
     MKMYGLGLRQ YFMSIFNRFD CFVVCSGILE ILLVESGAMT PLGISVLRCI RLLRLFKITK
     YWTSLSNLVA SLLNSIRSIA SLLLLLFLFM IIFALLGMQL FGGRYDFEDT EVRRSNFDNF
     PQALISVFQV LTGEDWNSVM YNGIMAYGGP SYPGVLVCIY FIILFVCGNY ILLNVFLAIA
     VDNLAEAESL TSAQKAKAEE RKRRKMSRGL PDKSEEERST MTKKLEQKPK GEGIPTTAKL
     KIDEFESNVN EVKDPYPSAD FPGDDEEDEP EIPASPRPRP LAELQLKEKA VPIPEASSFF
     IFSPTNKIRV LCHRIVNATW FTNFILLFIL LSSAALAAED PIRADSMRNQ ILEYFDYVFT
     AVFTVEIVLK MTTYGAFLHK GSFCRNYFNI LDLLVVAVSL ISMGLESSAI SVVKILRVLR
     VLRPLRAINR AKGLKHVVQC VFVAIRTIGN IVLVTTLLQF MFACIGVQLF KGKFYSCNDL
     SKMTEEECRG YYYIYKDGDP TQIELRPRQW IHNDFHFDNV LSAMMSLFTV STFEGWPQLL
     YKAIDSNEED TGPVYNNRVE MAIFFIIYII LIAFFMMNIF VGFVIVTFQE QGETEYKNCE
     LDKNQRQCVQ YALKARPLRC YIPKNPYQYQ VWYVVTSSYF EYLMFALIML NTICLGMQHY
     NQSEQMNHIS DILNVAFTII FTLEMILKLI AFKPRGYFGD PWNVFDFLIV IGSIIDVILS
     EIDTLLASSG GLYCLGGGCG NVDPDESARI SSAFFRLFRV MRLIKLLSRA EGVRTLLWTF
     IKSFQALPYV ALLIVMLFFI YAVIGMQMFG KIAMVDGTQI NRNNNFQTFP QAVLLLFRCA
     TGEAWQEILL ACSYGKRCDP ESDYAPGEEY ACGTNFAYYY FISFYMLCAF LIINLFVAVI
     MDNFDYLTRD WSILGPHHLD EFKAIWAEYD PEAKGRIKHL DVVTLLRRIQ PPLGFGKFCP
     HRVACKRLVG MNMPLNSDGT VTFNATLFAL VRTALKIKTE GNFEQANEEL RAIIKKIWKR
     TSMKLLDQVI PPIGDDEVTV GKFYATFLIQ EHFRKFMKRQ EEYYGYRPKK DTVQIQAGLR
     TIEEEAAPEI HRAISGDLTA EEELERAMVE AAMEEGIFRR TGGLFGQVDN FLERTNSLPP
     VMANQRPLQF AEMEMEELES PVFLEDFPQN PGTHPLARAN TNNANANVAY GNSSHRNSPV
     FSSIRYEREL LEEAGRPVTR EGPFSQPCSV SGVNSRSHVD KLERQMSQRR MPKGQVPPSP
     CQLSQEKHPV HEEGKGPRSW STETSDSESF EERVPRNSAH KCTAPATTML IQEALVRGGL
     DSLAADANFV MATGQALADA CQMEPEEVEV AATELLKRES PKGGAMPREP
//
